Validity of Euro Score in Patients


European score system has been used to predict the morbidity and mortality rate of the patients who underwent open heart surgery. This is an attempt to evaluate the validity of Euro SCORE in off-pump coronary artery bypass surgery at Afshar Heart Center. 367 consecutive patients who underwent primary or redo off-pump CABG in Afshar Heart Center during October 2010 to March 2011 were collected. The Euro SCORE forms were filled and incidence of post-operative morbidity and mortality were determined. The Patients were categorized into 4 groups of low-risk (logistic score: 0-1.99), medium-risk (logistic score: 2-10.99), high-risk (logistic score: 11-19.99) and severe risk (logistic score: 20-62.80). The mean patient age was 61.19±10.90 years including 66.8% male and 33.2% female. Overall average mortality rate was 4.4%. Hospital stay was 6.1±3.6 days. IABP was used in 3.8%. Major complications were renal failure, bleeding, arrhythmia, pulmonary emboli, CVA, respiratory failure and MI. Arrhythmia was the most common complication that was the cause of mortality. The mortality rates were 0%, 1.7%, 13.2%, and 38.9% in low, medium, high and severe-risk groups, respectively. Euro SCORE is valid in OPCAB to modify the risk stratification of the patients who underwent OPCAB.

uropean system for cardiac operative risk evaluation (EuroSCORE) was developed in Europe in the late 1990s. This calculation system can evaluate perioperative morbidity and mortality in patients undergoing cardiac surgery. EuroSCORE has been widely accepted in Europe and other countries. In most of the countries EuroSCORE system was used for on-pump coronary artery bypass grafting (CABG). Many studies showed that off-pump coronary artery bypass grafting needs recovery times less than on-pump technique. Nevertheless, we decided to evaluate our patients undergoing OPCAB with this risk calculation system. At Afshar Heart center the majority of the patients that need coronary artery bypass surgery underwent offpump technique. This is the first research in Iran that uses EuroSCORE for evaluation of morbidity and mortality in OPCAB. In this study the outcomes including major complications and mortality with EuroSCORE in OPCAB patients were evaluated

The Journal of Biology and Today’s World is a leading academic research journal, which publishes scholarly articles in the field of medicine and biology. This journal publishes the finest peer-reviewed research in all aspects of medicine and biology keeping in mind the originality, importance, accessibility, timeliness, elegance, and startling conclusions.

Due its broad scope, a diverse set of topics, such as genetics, biotechnology, biochemistry, microbiology, cellular & molecular biology, and disease biology, are covered under the aegis of this journal. Additionally, the journal also provides rapid, authoritative, and insightful reports and interpretation of topical and future trends in science.

Send your manuscript as an email attachment to our Editorial office at or

Jones Carrol